Facioscapulohumeral muscular dystrophy
- PMID: 29478599
- DOI: 10.1016/B978-0-444-64076-5.00035-1
Facioscapulohumeral muscular dystrophy
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common forms of muscular dystrophy with a distinctive pattern of skeletal muscle weakness and a wide spectrum of disease severity. The pathophysiologic consequences of the genetic lesion, the loss of a critical number of macrosatellite repeats (D4Z4) in the subtelomeric region of chromosome 4q35, remained unexplained for almost two decades. Recent studies demonstrate that contraction in the number of D4Z4 repeats results in chromatin relaxation and transcriptional de-repression of DUX4, a gene normally expressed only in the germline. In about 5% of individuals with phenotypic FSHD, there is no contraction in the D4Z4 repeats and yet similar chromatin changes are present, resulting in the inappropriate expression of the DUX4 gene. The chromatin changes in this form of FSHD (FSHD2) are the result, in most cases, of mutations in SMCHD1, a gene on chromosome 18 involved in chromatin regulation. The recent identification of aberrant activation of DUX4 transcription in FSHD as the root cause of FSHD now allows for a targeted approach to therapeutic development.
Keywords: DNA methylation; DUX4; FSH dystrophy; FSHD; SMCHD1; facioscapulohumeral muscular dystrophy.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.Neuromuscul Disord. 2016 Dec;26(12):844-852. doi: 10.1016/j.nmd.2016.09.015. Epub 2016 Sep 19. Neuromuscul Disord. 2016. PMID: 27816329 Review.
-
Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.Epigenetics Chromatin. 2018 Aug 20;11(1):47. doi: 10.1186/s13072-018-0215-z. Epigenetics Chromatin. 2018. PMID: 30122154 Free PMC article.
-
Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.Trends Mol Med. 2011 May;17(5):252-8. doi: 10.1016/j.molmed.2011.01.001. Epub 2011 Feb 1. Trends Mol Med. 2011. PMID: 21288772 Free PMC article. Review.
-
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.Neurotherapeutics. 2018 Oct;15(4):863-871. doi: 10.1007/s13311-018-00675-3. Neurotherapeutics. 2018. PMID: 30361930 Free PMC article. Review.
-
Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?Hum Genet. 2012 Mar;131(3):325-40. doi: 10.1007/s00439-011-1100-z. Epub 2011 Oct 9. Hum Genet. 2012. PMID: 21984394 Review.
Cited by
-
Rapid prenatal diagnosis of Facioscapulohumeral Muscular Dystrophy 1 by combined Bionano optical mapping and karyomapping.Prenat Diagn. 2020 Feb;40(3):317-323. doi: 10.1002/pd.5607. Epub 2019 Dec 2. Prenat Diagn. 2020. PMID: 31711258 Free PMC article.
-
Counseling and prenatal diagnosis in facioscapulohumeral muscular dystrophy: A retrospective study on a 13-year multidisciplinary approach.Health Sci Rep. 2022 Apr 20;5(3):e614. doi: 10.1002/hsr2.614. eCollection 2022 May. Health Sci Rep. 2022. PMID: 35509380 Free PMC article.
-
FSHD muscle shows perturbation in fibroadipogenic progenitor cells, mitochondrial function and alternative splicing independently of inflammation.Hum Mol Genet. 2024 Jan 7;33(2):182-197. doi: 10.1093/hmg/ddad175. Hum Mol Genet. 2024. PMID: 37856562 Free PMC article.
-
DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.Int J Mol Sci. 2020 Jan 22;21(3):729. doi: 10.3390/ijms21030729. Int J Mol Sci. 2020. PMID: 31979100 Free PMC article. Review.
-
Polymyositis: A Case Report.Cureus. 2023 Aug 11;15(8):e43337. doi: 10.7759/cureus.43337. eCollection 2023 Aug. Cureus. 2023. PMID: 37700938 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
